• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma.

作者信息

Gozzetti Alessandro, Defina Marzia, Bocchia Monica, Fabbri Alberto, Marchini Elena, Chitarrelli Ida, Lauria Francesco

出版信息

Leuk Res. 2010 Nov;34(11):e288-9. doi: 10.1016/j.leukres.2010.05.025. Epub 2010 Jun 16.

DOI:10.1016/j.leukres.2010.05.025
PMID:20557933
Abstract
摘要

相似文献

1
Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma.硼替佐米、美法仑及低剂量地塞米松（VM-地塞米松）用于新诊断的多发性骨髓瘤患者的安全性及有效性
Leuk Res. 2010 Nov;34(11):e288-9. doi: 10.1016/j.leukres.2010.05.025. Epub 2010 Jun 16.
2
[Combination of bortezomib and dexamethasone for newly diagnosed multiple myeloma].硼替佐米与地塞米松联合用于新诊断的多发性骨髓瘤
Zhonghua Xue Ye Xue Za Zhi. 2009 Aug;30(8):543-7.
3
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.硼替佐米-马法兰-泼尼松-沙利度胺序贯硼替佐米-沙利度胺维持治疗与硼替佐米-马法兰-泼尼松方案治疗初治多发性骨髓瘤的随机对照研究
J Clin Oncol. 2010 Dec 1;28(34):5101-9. doi: 10.1200/JCO.2010.29.8216. Epub 2010 Oct 12.
4
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma.硼替佐米、低剂量静脉注射美法仑及地塞米松用于复发的多发性骨髓瘤患者。
Br J Haematol. 2009 Mar;144(6):887-94. doi: 10.1111/j.1365-2141.2008.07572.x. Epub 2009 Jan 12.
5
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.硼替佐米联合美法仑和泼尼松用于多发性骨髓瘤的初始治疗。
N Engl J Med. 2008 Aug 28;359(9):906-17. doi: 10.1056/NEJMoa0801479.
6
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens.硼替佐米和地塞米松作为维持治疗在对挽救性硼替佐米为基础的方案有反应的晚期多发性骨髓瘤患者中的疗效和安全性。
Cancer. 2011 May 1;117(9):1884-90. doi: 10.1002/cncr.25743. Epub 2010 Nov 18.
7
Update on recent developments for patients with newly diagnosed multiple myeloma.新诊断多发性骨髓瘤患者的近期进展更新
Ann N Y Acad Sci. 2008 Sep;1138:19-21. doi: 10.1196/annals.1414.004.
8
[Efficacy of bortezomib combined dexamethasone in 24 patients with multiple myeloma].硼替佐米联合地塞米松治疗24例多发性骨髓瘤的疗效
Ai Zheng. 2008 Apr;27(4):429-34.
9
[PAD regimen for relapsed or refractory patients with multiple myeloma].复发或难治性多发性骨髓瘤患者的PAD方案
Zhonghua Xue Ye Xue Za Zhi. 2009 Apr;30(4):260-3.
10
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.硼替佐米作为自体移植前的诱导治疗，随后在未经治疗的多发性骨髓瘤患者中采用来那度胺进行巩固维持治疗。
J Clin Oncol. 2010 Feb 10;28(5):800-7. doi: 10.1200/JCO.2009.22.7561. Epub 2010 Jan 4.

引用本文的文献

1
Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study.轻链多发性骨髓瘤：一项长期研究中的临床特征、治疗反应及生存情况
World J Surg Oncol. 2014 Jul 28;12:234. doi: 10.1186/1477-7819-12-234.